![](https://monteverdelaw.com/wp-content/uploads/case-logo/oxford-immunotec-global-plc.jpg)
Oxford Immunotec Global PLC (OXFD) relating to its proposed sale to PerkinElmer, Inc. Under the terms of the agreement, OXFD shareholders will receive $22.00 in cash per share they own.
Oxford Immunotec Global PLC (OXFD) relating to its proposed sale to PerkinElmer, Inc. Under the terms of the agreement, OXFD shareholders will receive $22.00 in cash per share they own.